GGrantIndex
← Leaderboards

Sanjoy K Bhattacharya

University Of Miami School Of Medicine

$6,832,003
Attributed
$8,184,884
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,184,884 · 6

By mechanism

R01$5,474,454 · 2
U01$2,029,321 · 1
R03$450,606 · 1
P30$171,502 · 1
R13$59,001 · 1

Top collaborators

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Glaucoma

Research focus

GlaucomaTissuesTrabecular Meshwork StructureCellsPrimary Open Angle GlaucomaPreventProteinsPhysiologic Intraocular PressureBaseRegulationStretchingAqueousMouse ModelInsightMolecularPathogenesisPlayIn VitroResistanceFunctional DisorderExtracellular MatrixCadaverSignal TransductionEye Diseases

Grant awards (28)

Impaired phospholipid metabolism in glaucoma$383,750
R01 · FY2024 · EY · contact PI
Impaired phospholipid metabolism in glaucoma$383,750
R01 · FY2023 · EY · contact PI
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)$29,000
R13 · FY2023 · EY · contact PI
Impaired phospholipid metabolism in glaucoma$372,238
R01 · FY2022 · EY · contact PI
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)$1
R13 · FY2022 · EY · contact PI
Impaired phospholipid metabolism in glaucoma$383,750
R01 · FY2021 · EY · contact PI
Impaired phospholipid metabolism in glaucoma$229,404
R01 · FY2021 · EY · contact PI
Multiomics Core$171,502
P30 · FY2021 · EY · contact PI
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)$30,000
R13 · FY2021 · EY · contact PI
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$667,770
U01 · FY2018 · EY
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$675,414
U01 · FY2017 · EY
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$686,137
U01 · FY2016 · EY
Trabecular Meshwork Proteins in Glaucoma$382,500
R01 · FY2016 · EY · contact PI
Trabecular Meshwork Proteins in Glaucoma$374,850
R01 · FY2015 · EY · contact PI
Trabecular Meshwork Proteins in Glaucoma$374,850
R01 · FY2014 · EY · contact PI
Trabecular Meshwork Proteins in Glaucoma$363,375
R01 · FY2013 · EY · contact PI
Trabecular Meshwork Proteins in Glaucoma$372,960
R01 · FY2012 · EY · contact PI
Trabecular Meshwork Proteins in Glaucoma$184,800
R01 · FY2012 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$294,155
R01 · FY2010 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$297,126
R01 · FY2009 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$191,358
R01 · FY2009 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$291,183
R01 · FY2008 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$297,126
R01 · FY2007 · EY · contact PI
Proteomic Analyses of Human Trabecular Meshwork$148,568
R03 · FY2007 · EY · contact PI
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA$297,279
R01 · FY2006 · EY · contact PI
Proteomic Analyses of Human Trabecular Meshwork$149,038
R03 · FY2006 · EY · contact PI
Proteomic Analyses of Human Trabecular Meshwork$81,855
R03 · FY2005 · EY
Proteomic Analyses of Human Trabecular Meshwork$71,145
R03 · FY2005 · EY